FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction

FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction

SILVER SPRING, Md., April 23, 2020 /PRNewswire/ — The U.S. Food and Drug Administration has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmeti…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *